JP2011190199A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2011190199A5 JP2011190199A5 JP2010056428A JP2010056428A JP2011190199A5 JP 2011190199 A5 JP2011190199 A5 JP 2011190199A5 JP 2010056428 A JP2010056428 A JP 2010056428A JP 2010056428 A JP2010056428 A JP 2010056428A JP 2011190199 A5 JP2011190199 A5 JP 2011190199A5
- Authority
- JP
- Japan
- Prior art keywords
- rheumatoid arthritis
- administration
- administered
- bed
- active ingredient
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 206010039073 rheumatoid arthritis Diseases 0.000 claims description 9
- 239000003814 drug Substances 0.000 claims description 7
- 229940079593 drug Drugs 0.000 claims description 7
- 239000004480 active ingredient Substances 0.000 claims description 2
- FBOZXECLQNJBKD-ZDUSSCGKSA-N L-methotrexate Chemical compound C=1N=C2N=C(N)N=C(N)C2=NC=1CN(C)C1=CC=C(C(=O)N[C@@H](CCC(O)=O)C(O)=O)C=C1 FBOZXECLQNJBKD-ZDUSSCGKSA-N 0.000 claims 1
- 229960000485 methotrexate Drugs 0.000 claims 1
- 239000003435 antirheumatic agent Substances 0.000 description 1
- 230000000144 pharmacologic effect Effects 0.000 description 1
Priority Applications (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2010056428A JP2011190199A (ja) | 2010-03-12 | 2010-03-12 | 関節リウマチ薬 |
| PCT/JP2010/007262 WO2011111143A1 (ja) | 2010-03-12 | 2010-12-15 | 関節リウマチ薬 |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2010056428A JP2011190199A (ja) | 2010-03-12 | 2010-03-12 | 関節リウマチ薬 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2011190199A JP2011190199A (ja) | 2011-09-29 |
| JP2011190199A5 true JP2011190199A5 (enExample) | 2013-04-25 |
Family
ID=44562991
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2010056428A Pending JP2011190199A (ja) | 2010-03-12 | 2010-03-12 | 関節リウマチ薬 |
Country Status (2)
| Country | Link |
|---|---|
| JP (1) | JP2011190199A (enExample) |
| WO (1) | WO2011111143A1 (enExample) |
Families Citing this family (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2016201044A1 (en) | 2015-06-09 | 2016-12-15 | Danisco Us Inc | Osmotic burst encapsulates |
| WO2016201040A1 (en) | 2015-06-09 | 2016-12-15 | Danisco Us Inc. | Water-triggered enzyme suspension |
| WO2016201069A1 (en) | 2015-06-09 | 2016-12-15 | Danisco Us Inc | Low-density enzyme-containing particles |
| EP3601515A1 (en) | 2017-03-31 | 2020-02-05 | Danisco US Inc. | Delayed release enzyme formulations for bleach-containing detergents |
| BR112019027976A2 (pt) | 2017-06-30 | 2020-07-07 | Danisco Us Inc. | partículas de baixa aglomeração, contendo enzimas |
| CN111742041B (zh) | 2017-12-21 | 2023-06-06 | 丹尼斯科美国公司 | 包含耐热干燥剂的含酶的热熔细粒 |
| BR112020016068A2 (pt) | 2018-02-08 | 2020-12-08 | Danisco Us Inc. | Partículas cera termicamente resistente matriz para encapsulamento de enzima |
| WO2020047215A1 (en) | 2018-08-30 | 2020-03-05 | Danisco Us Inc | Enzyme-containing granules |
| BR112021022397A2 (pt) * | 2019-05-10 | 2021-12-28 | Synact Pharma Aps | Composição |
| CA3220753A1 (en) | 2021-06-21 | 2022-12-29 | Synact Pharma Aps | Salts of phenyl pyrrole aminoguanidine and polymorphs of phenyl pyrrole aminoguanidinium salts |
| CN117957318A (zh) | 2021-09-13 | 2024-04-30 | 丹尼斯科美国公司 | 含有生物活性物质的颗粒 |
-
2010
- 2010-03-12 JP JP2010056428A patent/JP2011190199A/ja active Pending
- 2010-12-15 WO PCT/JP2010/007262 patent/WO2011111143A1/ja not_active Ceased
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2011190199A5 (enExample) | ||
| JP2015057451A5 (enExample) | ||
| JP2010503695A5 (enExample) | ||
| JP2013541583A5 (enExample) | ||
| JP2015523407A5 (enExample) | ||
| JP2017506624A5 (enExample) | ||
| HK1221646A1 (zh) | 高剂量普利多匹定用於治疗亨廷顿舞蹈症的用途 | |
| JP2016147915A5 (enExample) | ||
| JP2015522630A5 (enExample) | ||
| JP2012193216A5 (enExample) | ||
| EA201492010A1 (ru) | Применение высокой дозы лахинимода для лечения рассеянного склероза | |
| JP2013209384A5 (enExample) | ||
| JP2016532516A5 (enExample) | ||
| JP2012505830A5 (enExample) | ||
| MX2015009546A (es) | Dosificacion aumentada de efavirenz para el tratamiento de cancer. | |
| JP2014058509A5 (enExample) | ||
| HRP20161796T1 (hr) | Farmaceutski pripravak za primjenu u tretmanu ili prevenciji deficijencije vitamina i minerala kod pacijenata podvrgnutih operaciji želučane premosnice | |
| JP2017531042A5 (enExample) | ||
| JP2016504361A5 (enExample) | ||
| SA516370446B1 (ar) | تركيبة صيدلانية مستقرة مضادة للدرن في صورة قرص قابل للتشتت يحتوي على حبيبات إيزونيازيد وحبيبات ريفابنتين، وعملية لتحضيرها | |
| HRP20220701T1 (hr) | Spojeni benzazepini za liječenje touretteova sindroma | |
| JP2015509934A5 (enExample) | ||
| JP2017530142A5 (enExample) | ||
| JP2017511307A5 (enExample) | ||
| RU2016145411A (ru) | Комбинация брекспипразола и налмефена, и ее применение для лечения синдрома химической зависимости |